Answer
Stivarga (regorafenib) is contraindicated in patients with hypersensitivity to regorafenib or any of the excipients listed in section 6.1.
Sources for this answer
- Stivarga 40 mg film coated tabletsBayer plc · emc · SmPC §4.3 Contraindications · Version 7Document updated
Sources checked